Who
Jeffrey H. Burbank
Director
Company insider
Files Form 4 as: Director, Artivion; Chief Executive Officer, NxStage Medical.
In numbers
- Trades disclosed
- 305
- Buys
- 0
- Sells
- 87
- Bought
- $0
- Sold
- $15.0M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 8 Jun 2006
- Last trade
- 18 May 2026
- Last filed
- 20 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 18 May 2026filed 20 May 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Code A | —7,576 at $0.00 | filing |
| 18 May 2026filed 20 May 2026 | AORT ArtivionMedical Devices | SEC FORM 4 Code A | —7,576 at $0.00 | filing |
| 22 May 2025filed 27 May 2025 | AORT ArtivionMedical Devices | SEC FORM 4 Code A | —6,325 at $0.00 | filing |
| 30 May 2024filed 3 Jun 2024 | AORT ArtivionMedical Devices | SEC FORM 4 Code A | —6,289 at $0.00 | filing |
| 6 Jun 2023filed 8 Jun 2023 | AORT ArtivionMedical Devices | SEC FORM 4 Code A | —9,709 at $0.00 | filing |
| 1 Jun 2022filed 3 Jun 2022 | AORT ArtivionMedical Devices | SEC FORM 4 Code A | $150K7,878 at $19.04 | filing |
| 1 Jun 2021filed 2 Jun 2021 | AORT ArtivionMedical Devices | SEC FORM 4 Code A | $130K4,423 at $29.39 | filing |
| 1 Jun 2020filed 2 Jun 2020 | AORT ArtivionMedical Devices | SEC FORM 4 Code A | $130K5,667 at $22.94 | filing |
| 5 May 2020filed 6 May 2020 | AORT ArtivionMedical Devices | SEC FORM 4 Code A | —1,178 at $0.00 | filing |
| 16 May 2019filed 17 May 2019 | AORT ArtivionMedical Devices | SEC FORM 4 Code A | —4,163 at $0.00 | filing |
| 21 Feb 2019filed 25 Feb 2019 | NxStage Medicaloption or derivative | SEC FORM 4 Code D | —39,062 at $0.00 | filing |
| 21 Feb 2019filed 25 Feb 2019 | NxStage Medicaloption or derivative | SEC FORM 4 Code D | —189,456 at $0.00 | filing |
| 21 Feb 2019filed 25 Feb 2019 | NxStage Medicaloption or derivative | SEC FORM 4 Code D | —175,256 at $0.00 | filing |
| 21 Feb 2019filed 25 Feb 2019 | NxStage Medicaloption or derivative | SEC FORM 4 Code D | —205,058 at $0.00 | filing |
| 21 Feb 2019filed 25 Feb 2019 | NxStage Medicaloption or derivative | SEC FORM 4 Code D | —268,159 at $0.00 | filing |
| 21 Feb 2019filed 25 Feb 2019 | NxStage Medicaloption or derivative | SEC FORM 4 Code D | —149,567 at $0.00 | filing |
| 21 Feb 2019filed 25 Feb 2019 | NxStage Medicaloption or derivative | SEC FORM 4 Code D | —34,928 at $0.00 | filing |
| 21 Feb 2019filed 25 Feb 2019 | NxStage Medical | SEC FORM 4 Code D | $23.4M781,646 at $30.00 | filing |
| 23 May 2018filed 25 May 2018 | AORT ArtivionMedical Devices | SEC FORM 4 Code A | —4,638 at $0.00 | filing |
| 14 Mar 2018filed 16 Mar 2018 | NxStage Medicaloption or derivative | SEC FORM 4 Code M | —36,273 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.